Companies in the News

11.5.2019

Program addresses aggressive cancers with RTK (HER2, ERBB3, FGFR1, FGFR2) and KRAS mutations

SAN DIEGO, November 5, 2019 — eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced the dosing of the first subject in the...

11.5.2019

EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced data on novel shared tumor-specific neoantigens (TSNA) arising from...

10.28.2019

Biotechnology Veteran David Hung, M.D. Launches Stealth Start-Up Focusing on the Foremost Unmet Needs in Oncology

Nuvation Bio's Proprietary Portfolio Includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates

NEW YORK, Oct. 28, 2019 /PRNewswire/ -- N...

10.9.2019

Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability

Issued: London and San Francisco

GlaxoSmithKline plc today announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to imp...

9.10.2019

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the WiSE CRT System for the treatment of heart failure.

he...

6.26.2019

  • Lead gene therapy candidate significantly reduced seizures and reversed early mortality in preclinical model of Dravet Syndrome

  • Company aims to maximize the potential of genomics-driven precision medicine by overcoming key limitations of viral gene therapy

  • Financing syndicate comprised of pr...

6.13.2019

Company Also Expands Board of Directors and Executive Management Team with Key Appointments

San Francisco – June 13, 2019 – BlackThorn Therapeutics, a clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, today...

6.12.2019

  • At record levels of 415 parts per million (ppm), the Earth’s atmosphere contains one trillion tons (one teraton) more carbon dioxide today than it did prior to the Industrial Revolution.

  • Increasing the carbon levels in agricultural soils from today’s levels of approximately 1% back to native leve...

5.15.2019

This Boston-based agricultural technology start-up is creating seed treatments that optimize the health of a plant in order to increase its yield. The aim is to use natural microbiology and tech to improve sustainability, profits for growers and, of course, consumer health. Currently, the company's seed t...

4.30.2019

Vividion Therapeutics snagged $82 million in an oversubscribed Series B funding round to bolster its cash holdings that will be used to advance the San Diego-based company’s lead programs into the clinic and broaden the early-stage pipeline of therapeutics against previously intractable drug targets.

The l...

Please reload